A Study to Assess the Long Term Effect, Safety and Metabolism of a Solifenacin Liquid Suspension in Participants 5 to 18 Years of Age With Neurogenic Detrusor Overactivity
Clinical trial NCT01565694 · COMPLETED
Trial details
- NCT number
- NCT01565694
- Sponsor
- Astellas Pharma Europe B.V.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-14
- Primary completion
- 2016-04-28
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.